Alejandra Guillermina Miranda-Díaz | Clinical Research | Women Researcher Award

Posted on by Popular Engineer

Prof. Dr. Alejandra Guillermina Miranda-Díaz | Clinical Research | Women Researcher Award

Alejandra Guillermina Miranda Díaz is a distinguished Professor and Researcher with extensive experience in the fields of general surgery, pharmacology, and clinical research. Having pursued a lifelong passion for surgery, she became a Medical Surgeon and Partero at the University of Guadalajara, later specializing in General Surgery and obtaining a Master’s in Medical Sciences and a Doctorate in Pharmacology. Her academic journey reflects a commitment to advancing medical research, particularly in inflammatory diseases and oxidative stress. Miranda Díaz has held significant roles in academia, such as coordinating master’s programs in Medical Sciences and mentoring numerous graduate students. Her expertise has led to collaborations with hospitals and medical professionals on various groundbreaking studies. Her research focuses on understanding the mechanisms of inflammation and oxidative stress, contributing significantly to advancements in clinical pharmacology and surgical practice.

Profile

Education 

Alejandra Guillermina Miranda Díaz’s educational background is rich and diverse, rooted in the University of Guadalajara. She began her academic journey with a Bachelor’s degree in Medicine (1971–1977), followed by an advanced specialization in General Surgery (1983). Driven by a deep interest in medical research, she pursued a Master’s in Medical Sciences (1992), and later, a Doctorate in Pharmacology (2003), solidifying her status as an expert in the field. These academic milestones, supported by a strong foundation in clinical surgery, enabled her to bridge the gap between practical medical procedures and theoretical scientific exploration. Throughout her career, she has been dedicated to applying her educational experience to improve medical knowledge, train future professionals, and contribute to groundbreaking research in fields such as inflammation, oxidative stress, and pharmacology.

Experience 

Alejandra Guillermina Miranda Díaz has dedicated over 40 years to both clinical practice and academic instruction. She began her career as a General Surgeon in the IMSS (Mexican Social Security Institute) in 1983, advancing through various leadership roles such as the Coordinator of the Laparoscopic Surgery Program and Sub-Director of the Medical Morning Shift at Hospital General Regional No. 45. In 2001, she transitioned to academia, becoming a Professor and Researcher in the Department of Physiology at the University of Guadalajara’s Center for Health Sciences. Her role as the Coordinator for various Master’s and Doctorate programs in Medical Sciences allowed her to shape the careers of numerous students. Her expertise has earned her a prominent place in the field, with notable distinctions such as membership in multiple medical associations and the System of National Researchers (SNI), where she holds the level II status until 2026.

Research Focus 

Alejandra Guillermina Miranda Díaz’s research primarily focuses on the role of inflammation and oxidative stress in various diseases, particularly in nephrology and metabolic disorders. Her research examines the complex mechanisms of these processes in conditions such as lupus nephritis, diabetes, and obesity. By studying toll-like receptors (TLRs) such as TLR7 and TLR9, Miranda Díaz explores how these receptors influence disease progression and contribute to inflammatory responses. Her work is pivotal in understanding the broader implications of oxidative stress and inflammation, offering potential therapeutic targets for chronic diseases. Currently, her research includes investigating how inflammation and oxidative stress affect renal function in lupus nephritis and exploring their potential links to metabolic syndrome and obesity. Her work fosters collaboration between medical institutions and researchers, aiming to improve patient care and medical treatment strategies through evidence-based scientific discoveries.

Publication Top Notes

  • The Role of TLRs in Obesity and Its Related Metabolic Disorders 🧬
  • The Expression of Toll-like Receptors (TLR7 and TLR9) in Class III and Class IV of Recently Diagnosed Lupus Nephritis with 12-Month Follow-Up 🧪
  • The Sigma-1 Receptor Exacerbates Cardiac Dysfunction Induced by Obstructive Nephropathy: A Role for Sexual Dimorphism 💖
  • Clinical Impact Using Low Dose Mycophenolate Mofetil with Tacrolimus on Acute Rejection, Infectious Diseases, and Non-Infectious Complications in Renal Transplant: A Single Hospital Experience in Mexico 🏥
  • The Effect of Enalapril, Losartan, or Not Antihypertensive on the Oxidative Status in Renal Transplant Recipients 🌱
  • Foods with Potential Prooxidant and Antioxidant Effects Involved in Parkinson’s Disease 🧠
  • The Role of Oxidative Stress in Physiopathology and Pharmacological Treatment with Pro- and Antioxidant Properties in Chronic Diseases ⚖️
  • The Effect of Visceral Abdominal Fat Volume on Oxidative Stress and Proinflammatory Cytokines in Subjects with Normal Weight, Overweight, and Obesity 🏃‍♀️

 

 

PERVIN OZKAN KURTGOZ | Nephrology | Best Researcher Award

Posted on by Popular EngineerLeave a Comment on PERVIN OZKAN KURTGOZ | Nephrology | Best Researcher Award

Dr PERVIN OZKAN KURTGOZ | Nephrology | Best Researcher Award

Nephrologist, University of Health Sciences, Kocaeli City Hospital, Department of Nephrology, Turkey

Dr. Pervin Ozkan Kurtgoz is a dedicated nephrologist at the University of Health Sciences, Kocaeli City Hospital. Born in 1984, she graduated from Istanbul University Cerrahpasa Faculty of Medicine. With a passion for advancing kidney health, Dr. Kurtgoz has made significant contributions to clinical research, particularly during the COVID-19 pandemic, focusing on its effects on hemodialysis patients. Her collaborative spirit and commitment to patient care have led to numerous publications in reputable medical journals, addressing critical topics such as anxiety in chronic illness, biomarkers in kidney disease, and infection management. Dr. Kurtgoz aims to improve patient outcomes through innovative research and interdisciplinary collaboration, positioning her as a leading figure in nephrology.

Profile

Orcid

Strengths for the Award

  1. Diverse Research Contributions: Dr. Kurtgoz has authored multiple significant publications in reputable journals, addressing critical issues in nephrology, especially related to COVID-19 and its impact on patients with chronic illnesses. This demonstrates a commitment to addressing pressing health concerns.
  2. Interdisciplinary Approach: The research spans various aspects of nephrology, including the psychological effects of the pandemic on patients, biomarkers in kidney diseases, and complications such as catheter infections. This broad focus indicates a well-rounded expertise and adaptability.
  3. Recent and Relevant Topics: The research is timely, particularly concerning the COVID-19 pandemic’s effects on vulnerable populations, highlighting Dr. Kurtgoz’s responsiveness to current global health challenges.
  4. Collaborative Research: Many publications include co-authors, showcasing Dr. Kurtgoz’s ability to collaborate effectively with peers and contribute to multidisciplinary teams, which is essential for impactful research.
  5. Publication Record: A solid number of publications, including several in high-impact journals, underscores a sustained research output and engagement with the scientific community.

Areas for Improvement

  1. Increased Citations: While the volume of publications is commendable, efforts could be made to increase the citation impact of these works. Engaging in more prominent conferences or collaborations may enhance visibility and citation rates.
  2. Broader Outreach: Expanding the scope of research to include more innovative methodologies or emerging areas in nephrology could strengthen Dr. Kurtgoz’s research portfolio.
  3. Patient-Centric Research: Incorporating more qualitative research focused on patient experiences and outcomes could enhance the relevance and applicability of findings in clinical practice.
  4. Grant Acquisition: Pursuing external funding opportunities could facilitate more extensive research projects, enhancing both the quality and quantity of future studies.

Education

Dr. Pervin Ozkan Kurtgoz graduated from Istanbul University Cerrahpasa Faculty of Medicine, where she received a comprehensive medical education. Her training laid a strong foundation in clinical practice and research methodologies, essential for her future career in nephrology. Throughout her studies, she developed a keen interest in kidney diseases and their complex interplay with systemic health issues, particularly in vulnerable populations such as those undergoing hemodialysis. Following her graduation, Dr. Kurtgoz further honed her expertise in nephrology, focusing on both clinical practice and research. Her academic background has equipped her with the skills to conduct impactful research, contribute to medical literature, and engage with healthcare professionals in improving patient care. Dr. Kurtgoz continues to pursue lifelong learning and professional development to stay at the forefront of nephrology, enhancing her ability to address the evolving challenges in kidney health.

Research Focus

Dr. Pervin Ozkan Kurtgoz’s research primarily focuses on nephrology, with a particular emphasis on the intersection of chronic kidney disease and systemic health challenges, especially during the COVID-19 pandemic. Her work explores the psychological impact of chronic illness on patients, investigating anxiety levels among those requiring hospitalization and the implications of these findings for patient care. Additionally, Dr. Kurtgoz studies various biomarkers related to kidney disease, such as sirtuin 1 and soluble klotho, aiming to better understand their roles in disease progression and complications. She also examines the prevalence of infections and complications in hemodialysis patients, contributing to improved management strategies. By addressing these critical areas, Dr. Kurtgoz aims to enhance patient outcomes, promote evidence-based practices, and foster interdisciplinary collaboration in nephrology research.

Publication Top Notes

  1. Performance of CO-RADS in the diagnosis of COVID-19 in hemodialysis patients 🦠
  2. The impact of COVID-19 pandemic on anxiety levels among chronic illness patients 😷
  3. The use of predialysis glucose as long term glycemic marker in hemodialysis patients 🍬
  4. Effect of anxiety on COVID-19 infection in hemodialysis patients 😟
  5. Evaluation of sirtuin 1 (SIRT1) levels in autosomal dominant polycystic kidney disease 🧬
  6. Relationship of soluble klotho level with uremic cardiomyopathy and echocardiographic parameters 💔
  7. Role of ADAMTS-1 in cyst development in autosomal dominant polycystic kidney disease 🔬
  8. Evaluation of catheter infections in kidney disease patients 🩺
  9. Effect of arterial stiffness on disease progression and mortality in chronic kidney patients 📉
  10. Thyroid disorders prevalence in kidney transplant recipients 🦋

Conclusion

Dr. Pervin Ozkan Kurtgoz demonstrates significant promise as a researcher in nephrology, with a commendable track record of publications, particularly addressing critical health issues such as COVID-19 and chronic kidney disease. The diverse research contributions and collaborative spirit position Dr. Kurtgoz as a strong candidate for the Best Researcher Award. By focusing on increasing the impact and outreach of her work, she can further enhance her contributions to the field and patient care.